美股市场个股详情

Catalyst Pharmaceuticals (CPRX)

添加自选
  • 27.370
  • -0.310-1.12%
收盘价 04/24 15:59 (美东)
  • 27.370
  • 0.0000.00%
盘后 20:01 (美东)
33.43亿总市值16.29市盈率TTM

Catalyst Pharmaceuticals (CPRX) 利润表

季报+年报
显示同比 yoy
隐藏空行 yoy
(FY)2025/12/31
(Q4)2025/12/31
(Q3)2025/09/30
(Q2)2025/06/30
(Q1)2025/03/31
(FY)2024/12/31
(Q4)2024/12/31
(Q3)2024/09/30
(Q2)2024/06/30
(Q1)2024/03/31
营业总收入
19.78%5.89亿
7.61%1.53亿
15.31%1.48亿
19.44%1.47亿
43.56%1.41亿
23.49%4.92亿
28.26%1.42亿
25.33%1.29亿
23.23%1.23亿
15.40%9,850.9万
营业收入
19.78%5.89亿
7.61%1.53亿
15.31%1.48亿
19.44%1.47亿
43.56%1.41亿
23.49%4.92亿
28.26%1.42亿
25.33%1.29亿
23.23%1.23亿
15.40%9,850.9万
主营业务成本
26.74%8,725.3万
20.47%2,607.4万
17.52%2,265.4万
33.81%2,061.4万
43.06%1,791.1万
32.48%6,884.5万
36.90%2,164.3万
36.07%1,927.7万
27.90%1,540.5万
25.88%1,252万
毛利
18.64%5.02亿
5.29%1.27亿
14.92%1.26亿
17.37%1.26亿
43.63%1.24亿
22.14%4.23亿
26.82%1.2亿
23.61%1.09亿
22.58%1.07亿
14.01%8,598.9万
营业费用
7.11%2.44亿
12.84%6,469.3万
1.64%5,947.1万
12.42%5,965.1万
2.17%6,014.3万
-12.20%2.28亿
8.04%5,733.4万
-53.46%5,850.9万
29.93%5,305.9万
47.86%5,886.3万
销售和管理费用
9.01%1.94亿
20.88%5,342.1万
3.47%4,747万
12.81%4,594.9万
-0.06%4,691.1万
32.93%1.78亿
5.13%4,419.2万
36.71%4,588万
43.44%4,073万
57.94%4,693.8万
-销售费用
9.79%1.22亿
9.54%3,359.8万
4.65%3,045.7万
7.76%2,828.4万
18.09%2,990.1万
28.44%1.11亿
6.01%3,067.1万
34.24%2,910.5万
43.33%2,624.7万
42.54%2,532.1万
-管理费用
7.70%7,151.1万
46.61%1,982.3万
1.42%1,701.3万
21.97%1,766.5万
-21.31%1,701万
41.20%6,639.6万
3.18%1,352.1万
41.22%1,677.5万
43.62%1,448.3万
80.83%2,161.7万
研发费用
0.48%1,270.9万
-52.42%180.7万
-19.09%265.7万
46.00%435.8万
50.60%388.7万
-86.42%1,264.8万
92.60%379.8万
-96.07%328.4万
-24.51%298.5万
-27.54%258.1万
折旧摊销及损耗
0.32%3,749.8万
1.29%946.5万
-0.01%934.4万
0.00%934.4万
0.01%934.5万
14.78%3,737.7万
3.15%934.4万
10.11%934.5万
10.08%934.4万
43.07%934.4万
-折旧及摊销
0.32%3,749.8万
1.29%946.5万
-0.01%934.4万
0.00%934.4万
0.01%934.5万
14.78%3,737.7万
3.15%934.4万
10.11%934.5万
10.08%934.4万
43.07%934.4万
营业利润
32.11%2.58亿
-1.59%6,184.6万
30.17%6,626.7万
22.22%6,629.8万
133.60%6,336.7万
124.77%1.95亿
50.73%6,284.3万
236.90%5,090.9万
16.16%5,424.6万
-23.82%2,712.6万
净非营业利息收入(费用)
54.16%2,476.5万
44.84%668.6万
51.14%685.7万
56.34%594.7万
69.78%527.5万
243.61%1,606.4万
224.39%461.6万
1,812.08%453.7万
109.82%380.4万
310.7万
利息收入
----
----
51.14%685.7万
56.34%594.7万
69.78%527.5万
----
----
--453.7万
--380.4万
--310.7万
其他财务费用
-54.16%-2,476.5万
----
----
----
----
-243.61%-1,606.4万
-224.39%-461.6万
-1,812.08%-453.7万
-109.82%-380.4万
----
其他净收入(费用)
-80.85%97.2万
-49.88%336.9万
-218.76%-208.9万
-30.50%-295.2万
331.12%264.4万
-34.08%507.5万
-18.69%672.2万
409.68%175.9万
-226.2万
-167.14%-114.4万
出售证券收益
-80.85%97.2万
-49.88%336.9万
-218.76%-208.9万
-30.50%-295.2万
331.12%264.4万
67.82%507.5万
87.14%672.2万
409.68%175.9万
---226.2万
---114.4万
其他非经营收入(费用)
----
----
----
----
----
----
----
----
----
15.20%196.3万
税前利润
31.10%2.84亿
-3.07%7,190.1万
24.18%7,103.5万
24.21%6,929.3万
145.06%7,128.6万
128.82%2.16亿
58.82%7,418.1万
250.46%5,720.5万
15.00%5,578.8万
-22.04%2,908.9万
所得税
32.11%6,918.9万
5.25%1,920.3万
37.02%1,825.2万
14.61%1,718.5万
150.24%1,454.9万
126.72%5,237.4万
53.80%1,824.5万
283.56%1,332.1万
39.48%1,499.4万
-24.93%581.4万
除税后利润
30.78%2.14亿
-5.79%5,269.8万
20.28%5,278.3万
27.73%5,210.8万
143.77%5,673.7万
129.50%1.64亿
60.53%5,593.6万
242.65%4,388.4万
8.03%4,079.4万
-21.28%2,327.5万
持续经营利润
30.78%2.14亿
-5.79%5,269.8万
20.28%5,278.3万
27.73%5,210.8万
143.77%5,673.7万
129.50%1.64亿
60.53%5,593.6万
242.65%4,388.4万
8.03%4,079.4万
-21.28%2,327.5万
归属于少数股东的净利润
归属于母公司的净利润
30.78%2.14亿
-5.79%5,269.8万
20.28%5,278.3万
27.73%5,210.8万
143.77%5,673.7万
129.50%1.64亿
60.53%5,593.6万
242.65%4,388.4万
8.03%4,079.4万
-21.28%2,327.5万
优先股派息
其他优先股派息
归属于普通股股东的净利润
30.78%2.14亿
-5.79%5,269.8万
20.28%5,278.3万
27.73%5,210.8万
143.77%5,673.7万
129.50%1.64亿
60.53%5,593.6万
242.65%4,388.4万
8.03%4,079.4万
-21.28%2,327.5万
基本每股收益
26.81%1.75
-8.51%0.43
16.22%0.43
22.86%0.43
135.00%0.47
105.97%1.38
42.42%0.47
227.59%0.37
-2.78%0.35
-28.57%0.2
稀释每股收益
28.24%1.68
-6.82%0.41
20.00%0.42
24.24%0.41
136.84%0.45
107.94%1.31
41.94%0.44
220.69%0.35
0.00%0.33
-26.92%0.19
每股派息
货币单位
美元
美元
美元
美元
美元
美元
美元
美元
美元
美元
会计准则
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
审计意见
无保留意见
--
--
--
--
无保留意见
--
--
--
--
(FY)2025/12/31(Q4)2025/12/31(Q3)2025/09/30(Q2)2025/06/30(Q1)2025/03/31(FY)2024/12/31(Q4)2024/12/31(Q3)2024/09/30(Q2)2024/06/30(Q1)2024/03/31
营业总收入 19.78%5.89亿7.61%1.53亿15.31%1.48亿19.44%1.47亿43.56%1.41亿23.49%4.92亿28.26%1.42亿25.33%1.29亿23.23%1.23亿15.40%9,850.9万
营业收入 19.78%5.89亿7.61%1.53亿15.31%1.48亿19.44%1.47亿43.56%1.41亿23.49%4.92亿28.26%1.42亿25.33%1.29亿23.23%1.23亿15.40%9,850.9万
主营业务成本 26.74%8,725.3万20.47%2,607.4万17.52%2,265.4万33.81%2,061.4万43.06%1,791.1万32.48%6,884.5万36.90%2,164.3万36.07%1,927.7万27.90%1,540.5万25.88%1,252万
毛利 18.64%5.02亿5.29%1.27亿14.92%1.26亿17.37%1.26亿43.63%1.24亿22.14%4.23亿26.82%1.2亿23.61%1.09亿22.58%1.07亿14.01%8,598.9万
营业费用 7.11%2.44亿12.84%6,469.3万1.64%5,947.1万12.42%5,965.1万2.17%6,014.3万-12.20%2.28亿8.04%5,733.4万-53.46%5,850.9万29.93%5,305.9万47.86%5,886.3万
销售和管理费用 9.01%1.94亿20.88%5,342.1万3.47%4,747万12.81%4,594.9万-0.06%4,691.1万32.93%1.78亿5.13%4,419.2万36.71%4,588万43.44%4,073万57.94%4,693.8万
-销售费用 9.79%1.22亿9.54%3,359.8万4.65%3,045.7万7.76%2,828.4万18.09%2,990.1万28.44%1.11亿6.01%3,067.1万34.24%2,910.5万43.33%2,624.7万42.54%2,532.1万
-管理费用 7.70%7,151.1万46.61%1,982.3万1.42%1,701.3万21.97%1,766.5万-21.31%1,701万41.20%6,639.6万3.18%1,352.1万41.22%1,677.5万43.62%1,448.3万80.83%2,161.7万
研发费用 0.48%1,270.9万-52.42%180.7万-19.09%265.7万46.00%435.8万50.60%388.7万-86.42%1,264.8万92.60%379.8万-96.07%328.4万-24.51%298.5万-27.54%258.1万
折旧摊销及损耗 0.32%3,749.8万1.29%946.5万-0.01%934.4万0.00%934.4万0.01%934.5万14.78%3,737.7万3.15%934.4万10.11%934.5万10.08%934.4万43.07%934.4万
-折旧及摊销 0.32%3,749.8万1.29%946.5万-0.01%934.4万0.00%934.4万0.01%934.5万14.78%3,737.7万3.15%934.4万10.11%934.5万10.08%934.4万43.07%934.4万
营业利润 32.11%2.58亿-1.59%6,184.6万30.17%6,626.7万22.22%6,629.8万133.60%6,336.7万124.77%1.95亿50.73%6,284.3万236.90%5,090.9万16.16%5,424.6万-23.82%2,712.6万
净非营业利息收入(费用) 54.16%2,476.5万44.84%668.6万51.14%685.7万56.34%594.7万69.78%527.5万243.61%1,606.4万224.39%461.6万1,812.08%453.7万109.82%380.4万310.7万
利息收入 --------51.14%685.7万56.34%594.7万69.78%527.5万----------453.7万--380.4万--310.7万
其他财务费用 -54.16%-2,476.5万-----------------243.61%-1,606.4万-224.39%-461.6万-1,812.08%-453.7万-109.82%-380.4万----
其他净收入(费用) -80.85%97.2万-49.88%336.9万-218.76%-208.9万-30.50%-295.2万331.12%264.4万-34.08%507.5万-18.69%672.2万409.68%175.9万-226.2万-167.14%-114.4万
出售证券收益 -80.85%97.2万-49.88%336.9万-218.76%-208.9万-30.50%-295.2万331.12%264.4万67.82%507.5万87.14%672.2万409.68%175.9万---226.2万---114.4万
其他非经营收入(费用) ------------------------------------15.20%196.3万
税前利润 31.10%2.84亿-3.07%7,190.1万24.18%7,103.5万24.21%6,929.3万145.06%7,128.6万128.82%2.16亿58.82%7,418.1万250.46%5,720.5万15.00%5,578.8万-22.04%2,908.9万
所得税 32.11%6,918.9万5.25%1,920.3万37.02%1,825.2万14.61%1,718.5万150.24%1,454.9万126.72%5,237.4万53.80%1,824.5万283.56%1,332.1万39.48%1,499.4万-24.93%581.4万
除税后利润 30.78%2.14亿-5.79%5,269.8万20.28%5,278.3万27.73%5,210.8万143.77%5,673.7万129.50%1.64亿60.53%5,593.6万242.65%4,388.4万8.03%4,079.4万-21.28%2,327.5万
持续经营利润 30.78%2.14亿-5.79%5,269.8万20.28%5,278.3万27.73%5,210.8万143.77%5,673.7万129.50%1.64亿60.53%5,593.6万242.65%4,388.4万8.03%4,079.4万-21.28%2,327.5万
归属于少数股东的净利润
归属于母公司的净利润 30.78%2.14亿-5.79%5,269.8万20.28%5,278.3万27.73%5,210.8万143.77%5,673.7万129.50%1.64亿60.53%5,593.6万242.65%4,388.4万8.03%4,079.4万-21.28%2,327.5万
优先股派息
其他优先股派息
归属于普通股股东的净利润 30.78%2.14亿-5.79%5,269.8万20.28%5,278.3万27.73%5,210.8万143.77%5,673.7万129.50%1.64亿60.53%5,593.6万242.65%4,388.4万8.03%4,079.4万-21.28%2,327.5万
基本每股收益 26.81%1.75-8.51%0.4316.22%0.4322.86%0.43135.00%0.47105.97%1.3842.42%0.47227.59%0.37-2.78%0.35-28.57%0.2
稀释每股收益 28.24%1.68-6.82%0.4120.00%0.4224.24%0.41136.84%0.45107.94%1.3141.94%0.44220.69%0.350.00%0.33-26.92%0.19
每股派息
货币单位 美元美元美元美元美元美元美元美元美元美元
会计准则 US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
审计意见 无保留意见--------无保留意见--------
热门市场机会
热门中概股
查看更多
中东战火燃至股市!投资者该如何应对?
据黎巴嫩媒体报道,当地时间27日凌晨,伊朗已通过中间人向美方传达了一个三阶段谈判方案,并表示若美接受方案,谈判即可恢复。谈判第一阶段重点是彻底结束战争,并避免对伊朗和黎巴嫩重新发动战争,第二阶段研究霍尔木兹海峡的管理,第三阶段与核问题讨论有关。市场同时聚焦关键时间窗口:5月1日 展开